Day One Biopharmaceuticals Stock Jumps on Renewed M&A Rumors
Day One Biopharmaceuticals shares surge 26% to $12.62 amid fresh speculation of a potential buyout.
Already have an account? Sign in.
Day One Biopharmaceuticals shares surge 26% to $12.62 amid fresh speculation of a potential buyout.
Instacart is exploring a sale that could value the company at $16–17 billion, with preliminary talks involving DoorDash and Uber.
Analysts upgrade AST SpaceMobile to Outperform after a sharp drop. Scotiabank cites SpaceX competition but sees value in AST’s wholesale 5G model.
Rina-S shows significant PFS and OS gains in platinum-resistant ovarian cancer, challenging Corcept’s Lifyorli position.
Be the first to know when deals break, stocks move, or biotech headlines hit.